CN1682806A - Ginseng and fleece-flower root dripping pill and its preparing method - Google Patents
Ginseng and fleece-flower root dripping pill and its preparing method Download PDFInfo
- Publication number
- CN1682806A CN1682806A CN 200510007422 CN200510007422A CN1682806A CN 1682806 A CN1682806 A CN 1682806A CN 200510007422 CN200510007422 CN 200510007422 CN 200510007422 A CN200510007422 A CN 200510007422A CN 1682806 A CN1682806 A CN 1682806A
- Authority
- CN
- China
- Prior art keywords
- polyethylene glycol
- ginseng
- substrate
- drug extract
- fleece
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The ginseng-fleeceflower root dripping pill has the functions of invigorating liver and kidney and benefiting vital energy and blood, and is used in treating lacking of essence and blood, prematurely grey hair and beard, neurosism, amnesia, insomnia, etc. The ginseng-fleeceflower root dripping pill is prepared with red ginseng and fleeceflower root as main material, and through extracting active components and further preparation with matrix carrier, and has high bioavailability, fast acting, high effective content, high active component content and low cost.
Description
Technical field
The present invention relates to a kind of invigorating the liver and kidney that has, the replenishing QI and blood effect, be used for the treatment of deficient qi and blood, early whitening of beard and hair, the neurasthenia, forgetful insomnia, inappetence, the pharmaceutical composition of diseases such as overfatigue is a kind of drug composition oral preparation that feedstock production forms with 2 flavor Chinese medicines such as Radix Ginseng Rubra, Radix Polygoni Multiflori Preparata particularly.
Background technology
According to drug standard WS promulgated by the ministries or commissions of the Central Government
3The ginseng polygona root extract that the preparation method that provides among-the B-0176-90 is prepared from, be a kind of invigorating the liver and kidney that has, the replenishing QI and blood effect is used for the treatment of deficient qi and blood, early whitening of beard and hair, the neurasthenia, forgetful insomnia, inappetence, the oral liquid of diseases such as overfatigue, through clinical verification, determined curative effect is the common drug that clinical and family is used for the treatment of above-mentioned disease.Below be drug standard WS
3Prescription that provides among-the B-0176-90 and technology and brief description:
Prescription: Radix Ginseng Rubra 400g, Radix Polygoni Multiflori Preparata 600g
Method for making: above two flavors are ground into fine powder, according to the percolation (11 pages of appendix) under fluid extract and the extractum item, make solvent with 30% ethanol, flooded 24 hours, carry out percolation with the speed of per minute 1-3ml, collect filtrate 830ml just, device is preserved in addition, continues percolation to colourless, after reclaiming ethanol, be concentrated into about 170ml in 70 ℃, put cold, merge with first filtrate, add water to 1000ml, static 3 days, get supernatant, promptly.
Function cures mainly: invigorating the liver and kidney, replenishing QI and blood.Be used for deficient qi and blood, early whitening of beard and hair, neurasthenia, forgetful insomnia, inappetence, overfatigue etc.
Owing to reasons such as technologies of preparing, the oral formulations of most drug, especially the oral formulations of Chinese medicine, exist all after taking that dissolve scattered time limit is long, dissolution is low, absorption is relatively poor, problem such as liver sausage first pass effect and bioavailability are lower, thereby influence the performance of drug effect, also directly affect therapeutic effect.And oral liquid also exist medicament contg low, take metering and be difficult to accurately, take or carry shortcomings such as inconvenience.
In addition, conventional peroral dosage form as tablet, capsule etc., because the technology of granulation is arranged, therefore can produce bigger dust pollution in preparation process, can staff's health be worked the mischief to a certain extent, also can cause certain pollution to environment simultaneously.Moreover, the complex manufacturing of conventional oral formulations, production cost is higher, thereby patient's drug cost is also improved thereupon, is unfavorable for improving the ability of seeking medical advice of extensive patients, also is unfavorable for improving the general health level of society.
Summary of the invention
Purpose of the present invention is to replenish existing be used for the treatment of deficient qi and blood, early whitening of beard and hair, the neurasthenia, forgetful insomnia, inappetence, the deficiency of the oral drug preparation of diseases such as overfatigue, a kind of bioavailability height is provided, and has quick release, fast produce effects, the medicament contg height, take accurate measurement, cheap, and portable ginseng and fleece-flower root dripping pill.
Ginseng and fleece-flower root dripping pill involved in the present invention is a raw material with 2 flavor Chinese medicines such as Radix Ginseng Rubra, Radix Polygoni Multiflori Preparata, after extraction obtains containing the extract of above two flavor Chinese medicine active pharmaceutical ingredients, is prepared from the pharmaceutically suitable carrier as substrate again.Be prepared by the following technical solutions, can obtain ginseng and fleece-flower root dripping pill involved in the present invention:
[preparation method]
1. the preparation of drug extract: with g or kg is unit, by weight, get 2 parts of Radix Ginseng Rubra, 3 parts of Radix Polygoni Multiflori Preparatas, more than two the flavor, be ground into coarse powder,, make solvent with 30% ethanol with reference to the percolation under 2000 editions Pharmacopoeia of People's Republic of China appendix IO fluid extracts and the extractum item, flooded 24 hours, speed with per minute 1-3ml is carried out percolation, collects filtrate just, and device is preserved in addition, continue percolation to colourless, after reclaiming ethanol, merge with first filtrate, being concentrated into relative density in 70 ℃ is 1.2~1.4 thick paste, or continue to make and be dried and crushed into dry powder, promptly.
2. substrate: Polyethylene Glycol
(2000~20000), one or more the mixture in pharmaceutically suitable carrier such as polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac;
3. proportioning: with g or kg is unit, by weight, and drug extract: substrate=1: 1~1: 9;
4. according to the given ratio of prescription, accurately take by weighing drug extract and substrate, be placed on heating while stirring in the heating container, standby until the fused solution that obtains containing drug extract and substrate and/or emulsion and/or suspension;
5. adopt homemade or general drop pill machine (as the TZDW-1 type drop pill machine of Changzheng Tianmin High Science ﹠ Technology Co., Ltd., Beijing's production), and the temperature control system of adjustment drop pill machine, make the water dropper temperature heating of drop pill machine and remain on (50~90) ℃, the temperature cooling of condensing agent also remains on (40~-5) ℃;
6. when treating that the temperature of condensing agent in dropping-pill machine head and the condensation column is stable respectively and reaching desired state of temperature, fused solution and/or the emulsion and/or the suspension that will contain drug extract and substrate, place in the water dropper jar of drop pill machine, splash in the condensing agent, condensing agent can be any one in liquid paraffin, methyl-silicone oil, the vegetable oil;
7. will shrink the drop pill taking-up of molding by the outlet of drop pill machine, remove the surface condensation agent, be drying to obtain.
Beneficial effect
According to drug standard WS promulgated by the ministries or commissions of the Central Government
3The ginseng polygona root extract that the preparation method that provides among-the B-0176-90 is prepared from, be a kind of invigorating the liver and kidney that has, the replenishing QI and blood effect is used for the treatment of deficient qi and blood, early whitening of beard and hair, the neurasthenia, forgetful insomnia, inappetence, the oral liquid of diseases such as overfatigue, through clinical verification, determined curative effect is the common drug that clinical and family is used for the treatment of above-mentioned disease.
Owing to reasons such as technologies of preparing, the oral formulations of most drug, especially the oral formulations of Chinese medicine, exist all after taking that dissolve scattered time limit is long, dissolution is low, absorption is relatively poor, problem such as liver sausage first pass effect and bioavailability are lower, thereby influence the performance of drug effect, also directly affect therapeutic effect.And oral liquid also exist medicament contg low, take metering and be difficult to accurately, take or carry shortcomings such as inconvenience.
In addition, conventional peroral dosage form as tablet, capsule etc., because the technology of granulation is arranged, therefore can produce bigger dust pollution in preparation process, can staff's health be worked the mischief to a certain extent, also can cause certain pollution to environment simultaneously.Moreover, the complex manufacturing of conventional oral formulations, production cost is higher, thereby patient's drug cost is also improved thereupon, is unfavorable for improving the ability of seeking medical advice of extensive patients, also is unfavorable for improving the general health level of society.
Ginseng and fleece-flower root dripping pill involved in the present invention is compared with the ginseng polygona root extract has following beneficial effect:
1. ginseng and fleece-flower root dripping pill involved in the present invention; utilize surfactant to be substrate; the extract of pharmaceutically active ingredient is made solid dispersion in containing two flavors such as Radix Ginseng Rubra, Radix Polygoni Multiflori; making medicine be molecule, colloid or microcrystalline state is scattered in the substrate; the total surface area of medicine increases; and substrate is hydrophilic; medicine had wetting action; can make medicine molten microgranule or the solution of loosing into rapidly; thereby make the dissolving of medicine and absorb quickening; thereby improved bioavailability, brought into play efficient, quick-acting effects etc.
2. ginseng and fleece-flower root dripping pill involved in the present invention, contact promptly with saliva and to dissolve rapidly, and absorb by oral mucosa, not only rapid-action, and the influence of not taken food, promptly all can containing take after meal ante cibum, can not produce any residual harmful substance at gastric yet, thereby make that patient's medication is safer, also have medication convenience, characteristic of accurate simultaneously.
3. ginseng and fleece-flower root dripping pill involved in the present invention mixes the extract that contains active constituents of medicine mutually with molten matrix, splashes in the not miscible condensed fluid and makes.Therefore, the stability of drug height, not facile hydrolysis, oxidation, and the operation be under liquid state, to carry out, no dust pollution is not subject to the influence of crystal formation, thereby has guaranteed the quality of medicine, has increased stability.
4. production technology, the equipment of preparation drop pill are simple, easy to operate, the automaticity height, and labor intensity is low, the production efficiency height.Workshop does not have dust simultaneously, helps labor protection and environmental protection yet.
5. the production cost of preparation drop pill is usually with about 50% of other oral formulations of kind, and compares with oral liquid, and the dosage of drop pill is accurate, thereby makes the patient take metering control easily.
The specific embodiment
Now with several groups of specific embodiments, be described further with regard to the preparation method of ginseng and fleece-flower root dripping pill of the present invention.
First group: the test of single-matrix
1. the preparation of drug extract: be prepared according to preparation method 1, the extract dry powder that obtains containing pharmaceutically active ingredient in two flavors such as Radix Ginseng Rubra, Radix Polygoni Multiflori is standby;
2. substrate: Polyethylene Glycol
(2000,4000,6000,8000,10000,20000), polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac;
3. proportioning: with g or kg is unit, by weight, and drug extract: substrate=1: 1~1: 9;
4. the process that provides according to [preparation method] 4~7 is prepared, and can obtain the ginseng and fleece-flower root dripping pill of different size.
[result of the test]
Test 1: for observe drug extract and different substrates when 1: 1 the proportioning prepared ginseng and fleece-flower root dripping pill in qualitative difference, according to 1: 1 ratio, with drug extract respectively with Polyethylene Glycol
2000, Polyethylene Glycol
4000, Polyethylene Glycol
6000, Polyethylene Glycol
8000, Polyethylene Glycol
10000, Polyethylene Glycol
20000, pharmaceutically suitable carrier such as polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac matches, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain 15 pharmaceutical compositions experiments that contain drug extract and different substrates, and obtain 15 groups of different experimental results and see Table 1.
Test 2: for observe drug extract and different substrates when 1: 3 the proportioning prepared ginseng and fleece-flower root dripping pill in qualitative difference, according to 1: 3 ratio, with drug extract respectively with Polyethylene Glycol
2000, Polyethylene Glycol
4000, Polyethylene Glycol
6000, Polyethylene Glycol
8000, Polyethylene Glycol
10000, Polyethylene Glycol
20000, pharmaceutically suitable carrier such as polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac matches, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain 15 pharmaceutical compositions experiments that contain drug extract and different substrates, and obtain 15 groups of different experimental results and see Table 2.
Test 3: for observe drug extract and different substrates when 1: 9 the proportioning prepared ginseng and fleece-flower root dripping pill in qualitative difference, according to 1: 9 ratio, with drug extract respectively with Polyethylene Glycol
2000, Polyethylene Glycol
4000, Polyethylene Glycol
6000, Polyethylene Glycol
8000, Polyethylene Glycol
10000, Polyethylene Glycol
20000, pharmaceutically suitable carrier such as polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac matches, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain 15 pharmaceutical compositions experiments that contain drug extract and different substrates, and obtain 15 groups of different experimental results and see Table 3.
Second group: the test of mixed-matrix
1. the preparation of drug extract: be prepared according to preparation method 1, the extract dry powder that obtains containing pharmaceutically active ingredient in two flavors such as Radix Ginseng Rubra, Radix Polygoni Multiflori is standby;
2. substrate:
2.1 Polyethylene Glycol---English name Macrogol,
2.2 polyoxyethylene stearate 40 esters---English name Polyoxyl (40) Stearate,
Molecular formula is with C
17H
35COO (CH
2CH
2O)
nH represents that n is about 40,
2.3 poloxamer---English name Poloxamer, polyoxyethylene poly-oxygen propylene aether,
Molecular formula HO (C
2H
4O)
a(C
3H
6O)
b(C
2H
4O)
cH,
The sodium salt of the starch carboxymethyl ester that 2.4 carboxymethyl starch sodium---English name Carboxymethylstach Sodium, starch generates with the monoxone effect under alkali condition,
2.5 betacyclodextrin---English name Betacyclodextrin, molecular formula C
6H
10O
5, this product is that ring dextrin glucosyl transferase acts on 7 glucoses that starch generates with α-1, the bonded cyclic oligosaccharide of 4-glycosidic bond;
3. proportioning: with g or kg is unit, by weight, and drug extract: substrate=1: 1~1: 9;
4. the process that provides according to [preparation method] 4~7 is prepared, and can obtain the ginseng and fleece-flower root dripping pill of different size.
[result of the test]
Test 4: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared ginseng and fleece-flower root dripping pill when 1: 1 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 1 mixed evenly as mixed-matrix, according to 1: 1 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 4.
Test 5: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared ginseng and fleece-flower root dripping pill when 1: 3 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 1 mixed evenly as mixed-matrix, according to 1: 3 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 5.
Test 6: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared ginseng and fleece-flower root dripping pill when 1: 9 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 1 mixed evenly as mixed-matrix, according to 1: 9 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 6.
Test 7: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared ginseng and fleece-flower root dripping pill when 1: 1 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 5 mixed evenly as mixed-matrix, according to 1: 1 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 7.
Test 8: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared ginseng and fleece-flower root dripping pill when 1: 3 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 5 mixed evenly as mixed-matrix, according to 1: 3 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 8.
Test 9: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared ginseng and fleece-flower root dripping pill when 1: 9 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 5 mixed evenly as mixed-matrix, according to 1: 9 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 9.
Test 10: in order to observe the mass discrepancy of drug extract and mixed-matrix obtained ginseng and fleece-flower root dripping pill when 1: 1 proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 10 mixed evenly as mixed-matrix, according to 1: 1 ratio drug extract is mixed mutually with 4 kinds of different mixed-matrixes respectively again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 10.
Test 11: in order to observe the mass discrepancy of drug extract and mixed-matrix obtained ginseng and fleece-flower root dripping pill when 1: 3 proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 10 mixed evenly as mixed-matrix, according to 1: 3 ratio drug extract is mixed mutually with 4 kinds of different mixed-matrixes respectively again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 11.
Test 12: in order to observe the mass discrepancy of drug extract and mixed-matrix obtained ginseng and fleece-flower root dripping pill when 1: 9 proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 10 mixed evenly as mixed-matrix, according to 1: 9 ratio drug extract is mixed mutually with 4 kinds of different mixed-matrixes respectively again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 12.
The group practices of table 1 drug extract and single-matrix
(drug extract: substrate=1: 1)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyethylene Glycol 2000 | ????50.0 | ????62 | ????<30 | ????>10 | + |
Polyethylene Glycol 4000 | ????50.0 | ????75 | ????<30 | ????>10 | + |
Polyethylene Glycol 6000 | ????50.0 | ????76 | ????<30 | ????>10 | ++ |
Polyethylene Glycol 8000 | ????50.0 | ????76 | ????<30 | ????>10 | ++ |
Polyethylene Glycol 10000 | ????50.0 | ????78 | ????<30 | ????>10 | ++ |
Polyethylene Glycol 20000 | ????50.0 | ????78 | ????<30 | ????>10 | ++ |
Polyoxyethylene stearate 40 esters | ????50.0 | ????73 | ????<30 | ????>10 | ++ |
Betacyclodextrin | ????50.0 | ????69 | ????<30 | ????>10 | + |
Poloxamer | ????50.0 | ????75 | ????<30 | ????>10 | ++ |
Carboxymethyl starch sodium | ????50.0 | ????73 | ????<30 | ????>10 | + |
Sodium lauryl sulphate | ????50.0 | ????68 | ????>30 | ????>10 | ++ |
Stearic acid | ????50.0 | ????55 | ????>30 | ????>10 | ++ |
Sodium stearate | ????50.0 | ????55 | ????>30 | ????>10 | ++ |
Glycerin gelatine | ????50.0 | ????57 | ????>30 | ????>10 | + |
Lac | ????50.0 | ????56 | ????>30 | ????>10 | + |
The group practices of table 2 drug extract and single-matrix
(drug extract: substrate=1: 3)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyethylene Glycol 2000 | ????25.0 | ????79 | ????<30 | ????>10 | ++ |
Polyethylene Glycol 4000 | ????25.0 | ????86 | ????<30 | ????<10 | +++ |
Polyethylene Glycol 6000 | ????25.0 | ????91 | ????<30 | ????<10 | +++ |
Polyethylene Glycol 8000 | ????25.0 | ????91 | ????<30 | ????<10 | +++ |
Polyethylene Glycol 10000 | ????25.0 | ????92 | ????<30 | ????<10 | +++ |
Polyethylene Glycol 20000 | ????25.0 | ????92 | ????<30 | ????<10 | +++ |
Polyoxyethylene stearate 40 esters | ????25.0 | ????93 | ????<30 | ????<10 | ++ |
Betacyclodextrin | ????25.0 | ????83 | ????<30 | ????>10 | ++ |
Poloxamer | ????25.0 | ????91 | ????<30 | ????<10 | +++ |
Carboxymethyl starch sodium | ????25.0 | ????86 | ????<30 | ????<10 | +++ |
Sodium lauryl sulphate | ????25.0 | ????77 | ????<30 | ????>10 | ++ |
Stearic acid | ????25.0 | ????73 | ????>30 | ????>10 | +++ |
Sodium stearate | ????25.0 | ????71 | ????>30 | ????>10 | +++ |
Glycerin gelatine | ????25.0 | ????70 | ????>30 | ????>10 | +++ |
Lac | ????25.0 | ????70 | ????>30 | ????>10 | +++ |
The group practices of table 3 drug extract and single-matrix
(drug extract: substrate=1: 9)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyethylene Glycol 2000 | ????10.0 | ????81 | ????<30 | ????>10 | ++ |
Polyethylene Glycol 4000 | ????10.0 | ????88 | ????<30 | ????<10 | +++ |
Polyethylene Glycol 6000 | ????10.0 | ????91 | ????<30 | ????<10 | +++ |
Polyethylene Glycol 8000 | ????10.0 | ????91 | ????<30 | ????<10 | +++ |
Polyethylene Glycol 10000 | ????10.0 | ????92 | ????<30 | ????<10 | +++ |
Polyethylene Glycol 20000 | ????10.0 | ????92 | ????<30 | ????<10 | +++ |
Polyoxyethylene stearate 40 esters | ????10.0 | ????91 | ????<30 | ????<10 | ++ |
Betacyclodextrin | ????10.0 | ????84 | ????<30 | ????<10 | ++ |
Poloxamer | ????10.0 | ????87 | ????<30 | ????<10 | +++ |
Carboxymethyl starch sodium | ????10.0 | ????84 | ????<30 | ????>10 | +++ |
Sodium lauryl sulphate | ????10.0 | ????78 | ????<30 | ????>10 | +++ |
Stearic acid | ????10.0 | ????75 | ????>30 | ????>10 | +++ |
Sodium stearate | ????10.0 | ????73 | ????>30 | ????>10 | +++ |
Glycerin gelatine | ????10.0 | ????73 | ????>30 | ????>10 | +++ |
Lac | ????10.0 | ????72 | ????>30 | ????>10 | +++ |
The group practices of table 4 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 1)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 1 | ????50 | ????84 | ????<30 | ????>10 | ++ |
Poloxamer: Polyethylene Glycol=1: 1 | ????50 | ????82 | ????<30 | ????>10 | ++ |
Carboxymethyl starch sodium: Polyethylene Glycol=1: 1 | ????50 | ????79 | ????<30 | ????>10 | ++ |
Betacyclodextrin: Polyethylene Glycol=1: 1 | ????50 | ????72 | ????<30 | ????>10 | + |
The group practices of table 5 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 3)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 1 | ????25 | ????88 | ????<30 | ????<10 | +++ |
Poloxamer: Polyethylene Glycol=1: 1 | ????25 | ????89 | ????<30 | ????<10 | +++ |
Carboxymethyl starch sodium: Polyethylene Glycol=1: 1 | ????25 | ????86 | ????<30 | ????<10 | +++ |
Betacyclodextrin: Polyethylene Glycol=1: 1 | ????25 | ????82 | ????<30 | ????>10 | ++ |
The group practices of table 6 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 9)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 1 | ????10 | ????88 | ????<30 | ????<10 | +++ |
Poloxamer: Polyethylene Glycol=1: 1 | ????10 | ????86 | ????<30 | ????<10 | +++ |
Carboxymethyl starch sodium: Polyethylene Glycol=1: 1 | ????10 | ????83 | ????<30 | ????>10 | +++ |
Betacyclodextrin: Polyethylene Glycol=1: 1 | ????10 | ????80 | ????<30 | ????>10 | +++ |
The group practices of table 7 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 1)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 5 | ????50 | ????91 | ????<30 | ????<10 | +++ |
Poloxamer: Polyethylene Glycol=1: 5 | ????50 | ????90 | ????<30 | ????<10 | +++ |
Carboxymethyl starch sodium: Polyethylene Glycol=1: 5 | ????50 | ????90 | ????<30 | ????<10 | +++ |
Betacyclodextrin: Polyethylene Glycol=1: 5 | ????50 | ????86 | ????<30 | ????<10 | ++ |
The group practices of table 8 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 3)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 5 | ????25 | ????93 | ????<30 | ????<10 | +++ |
Poloxamer: Polyethylene Glycol=1: 5 | ????25 | ????93 | ????<30 | ????<10 | +++ |
Carboxymethyl starch sodium: Polyethylene Glycol=1: 5 | ????25 | ????91 | ????<30 | ????<10 | +++ |
Betacyclodextrin: Polyethylene Glycol=1: 5 | ????25 | ????88 | ????<30 | ????<10 | +++ |
The group practices of table 9 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 9)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 5 | ????10 | ????93 | ????<30 | ????<10 | +++ |
Poloxamer: Polyethylene Glycol=1: 5 | ????10 | ????92 | ????<30 | ????<10 | +++ |
Carboxymethyl starch sodium: Polyethylene Glycol=1: 5 | ????10 | ????92 | ????<30 | ????<10 | +++ |
Betacyclodextrin: Polyethylene Glycol=1: 5 | ????10 | ????89 | ????<30 | ????<10 | +++ |
The group practices of table 10 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 1)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 10 | ????50 | ????92 | ????<30 | ????<10 | +++ |
Poloxamer: Polyethylene Glycol=1: 10 | ????50 | ????91 | ????<30 | ????<10 | +++ |
Carboxymethyl starch sodium: Polyethylene Glycol=1: 10 | ????50 | ????87 | ????<30 | ????<10 | +++ |
Betacyclodextrin: Polyethylene Glycol=1: 10 | ????50 | ????84 | ????<30 | ????>10 | +++ |
The group practices of table 11 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 3)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 10 | ????25 | ????92 | ????<30 | ????<10 | +++ |
Poloxamer: Polyethylene Glycol=1: 10 | ????25 | ????92 | ????<30 | ????<10 | +++ |
Carboxymethyl starch sodium: Polyethylene Glycol=1: 10 | ????25 | ????89 | ????<30 | ????<10 | +++ |
Betacyclodextrin: Polyethylene Glycol=1: 10 | ????25 | ????87 | ????<30 | ????<10 | +++ |
The group practices of table 12 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 9)
The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 10 | ????10 | ????91 | ????<30 | ????<10 | +++ |
Poloxamer: Polyethylene Glycol=1: 10 | ????10 | ????92 | ????<30 | ????<10 | +++ |
Carboxymethyl starch sodium: Polyethylene Glycol=1: 10 | ????10 | ????91 | ????<30 | ????<10 | +++ |
Betacyclodextrin: Polyethylene Glycol=1: 10 | ????10 | ????91 | ????<30 | ????<10 | +++ |
1. can be seen by the result in the table: when the ratio of drug extract and substrate was 1: 1, its rounding rate, the ball method of double differences was different and index such as hardness is all undesirable, and dissolve scattered time limit influenced not obvious.
2. when the ratio of drug extract and substrate is 1: 3, the rounding rate, the ball method of double differences is different and index such as hardness slightly all begins to enter preferable state.
3. when the ratio of drug extract and substrate is 1: 9, the rounding rate, the ball method of double differences is different and index such as hardness improves not obvious.
4. the general effect of composite interstitial substance is better than single-matrix.
5. the hardness method for expressing in the subordinate list adopts drop pill is placed on the glass plate, press...withes one's finger it, observes its metamorphosis."+" expression flicking promptly is out of shape, " ++ " expression distortion of firmly pressing, and " +++" expression is indeformable by it.
Claims (6)
1. one kind is used for the treatment of deficient qi and blood, early whitening of beard and hair, the neurasthenia, forgetful insomnia, inappetence, the pharmaceutical composition ginseng and fleece-flower root dripping pill of diseases such as overfatigue is a raw material with the extract that contains 2 flavor active ingredient of Chinese herbs such as Radix Ginseng Rubra, Radix Polygoni Multiflori, be prepared from pharmaceutically suitable carrier as substrate, wherein:
1.1 with g or kg is unit, by weight, gets 3 parts Flos Lonicerae and 7 parts Caulis Lonicerae, makes the extract thick paste or the dry powder that contain 2 flavor active ingredient of Chinese herbs such as Radix Ginseng Rubra, Radix Polygoni Multiflori in advance, standby;
1.2 substrate---Polyethylene Glycol
(2000~20000), polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac, the mixture of wherein one or more;
1.3 proportioning---with g or kg is unit, by weight, and drug extract: substrate=1: 1~1: 9.
2. ginseng and fleece-flower root dripping pill as claimed in claim 1 is characterized in that: described substrate is the mixture of Polyethylene Glycol and polyoxyethylene stearate 40 esters or Polyethylene Glycol and poloxamer or Polyethylene Glycol and carboxymethyl starch sodium or Polyethylene Glycol and betacyclodextrin; With g or kg is unit, and by weight, its mixed proportion is polyoxyethylene stearate 40 esters: Polyethylene Glycol or poloxamer: Polyethylene Glycol or carboxymethyl starch sodium: Polyethylene Glycol or betacyclodextrin: Polyethylene Glycol=1: 1~1: 10.
3. any ginseng and fleece-flower root dripping pill as claimed in claim 1 or 2 is characterized in that: the mixed proportion of described drug extract and substrate is 1: 1~1: 5.
4. the preparation method of a ginseng and fleece-flower root dripping pill is characterized in that being made of following process:
4.1 with g or kg is unit, by weight, gets 3 parts Flos Lonicerae and 7 parts Caulis Lonicerae, makes the extract thick paste or the dry powder that contain 2 flavor active ingredient of Chinese herbs such as Radix Ginseng Rubra, Radix Polygoni Multiflori in advance, standby;
4.2 substrate: Polyethylene Glycol
(2000~20000), polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac, the mixture of wherein one or more;
4.3 proportioning: with g or kg is unit, by weight, and drug extract: substrate=1: 1~1: 9;
4.4, accurately take by weighing drug extract and substrate according to the given ratio of prescription, be placed on heating while stirring in the heating container, standby until the fused solution that obtains containing drug extract and substrate and/or emulsion and/or suspension;
4.5 adopt homemade or general drop pill machine (as the TZDW-1 type drop pill machine of Changzheng Tianmin High Science ﹠ Technology Co., Ltd., Beijing's production), and the temperature control system of adjustment drop pill machine, make the water dropper temperature heating of drop pill machine and remain on (50~90) ℃, the temperature cooling of condensing agent also remains on (40~-5) ℃;
4.6 treating that the temperature of condensing agent in dropping-pill machine head and the condensation column is stable respectively is in above the 2nd step during desired state of temperature, fused solution and/or the emulsion and/or the suspension that will contain drug extract and substrate, under the temperature conditions close, make evenly through fully stirring with the water dropper temperature, place in the water dropper jar of drop pill machine, splash in the condensing agent by water dropper, shrink molding promptly.
5. as the preparation method of ginseng and fleece-flower root dripping pill as described in the claim 4, it is characterized in that: method 4.6 described condensing agents are methyl-silicone oils or/and liquid paraffin or/and vegetable oil.
6. the preparation method of ginseng and fleece-flower root dripping pill as claimed in claim 1 or ginseng and fleece-flower root dripping pill as claimed in claim 4, it is characterized in that being prepared as follows of described drug extract: with g or kg is unit, by weight, get 3 parts Flos Lonicerae and 7 parts Caulis Lonicerae, more than two the flavor, Flos Lonicerae is distilled with the way of distillation, collects distillate, and is standby; Medicinal residues and Caulis Lonicerae add water at 80 ℃ of dipping secondaries, each 1 hour, filter, merging filtrate, and add above-mentioned distillate is condensed into relative density and is 1.3~1.35 thick paste under decompression (0.1MPa), low temperature (60 ℃) condition, or continue dry in the above conditions, be ground into dry powder, promptly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510007422 CN1682806A (en) | 2005-02-18 | 2005-02-18 | Ginseng and fleece-flower root dripping pill and its preparing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510007422 CN1682806A (en) | 2005-02-18 | 2005-02-18 | Ginseng and fleece-flower root dripping pill and its preparing method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1682806A true CN1682806A (en) | 2005-10-19 |
Family
ID=35262425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510007422 Pending CN1682806A (en) | 2005-02-18 | 2005-02-18 | Ginseng and fleece-flower root dripping pill and its preparing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1682806A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102657358A (en) * | 2012-06-05 | 2012-09-12 | 李三猛 | Drink for preventing white hair |
CN107874255A (en) * | 2017-11-13 | 2018-04-06 | 吉林省瑞草园科技有限公司 | A kind of ginseng is base source health food for relieving physical fatigue and preparation method thereof |
-
2005
- 2005-02-18 CN CN 200510007422 patent/CN1682806A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102657358A (en) * | 2012-06-05 | 2012-09-12 | 李三猛 | Drink for preventing white hair |
CN107874255A (en) * | 2017-11-13 | 2018-04-06 | 吉林省瑞草园科技有限公司 | A kind of ginseng is base source health food for relieving physical fatigue and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1660368A (en) | Oral drop pill in use for clearing away heat and toxic material and preparation method | |
CN1682923A (en) | Body strengthening dripping pill for invigorating qi and refreshing and its preparing method | |
CN100341487C (en) | 'Shuanghuang' antiphlogistic drop pill in use relieving inflammation and preparation method | |
CN100341489C (en) | Xianling gubao dripping pills having functions of reinforcing kidney strengthening bone, and its prepn method | |
CN1316961C (en) | Grosvenor's momordica fruit drip pill an dits preparation method | |
CN1686342A (en) | Herminium drip pill and its preparation method | |
CN1682918A (en) | Tranquilizing wild jujube seed dripping pill and its preparing method | |
CN1292741C (en) | Ginseng and schisandra fruit dripping pill and its preparing method | |
CN1316959C (en) | Acanthopanax bark-ginseng-Chinese angelica root-astragalus root dripping pill and its preparing method | |
CN100344314C (en) | Xinnaoshu dripping pill for invigorating qi and nourishing yin and its preparing method | |
CN1682806A (en) | Ginseng and fleece-flower root dripping pill and its preparing method | |
CN1292738C (en) | Ginseng-pilose antler dripping pill for tonifying heart and kidney and its preparing method | |
CN1682920A (en) | Anshenning dripping pill for treating neurosism and its preparing method | |
CN1307983C (en) | Mai-an dripping pill for treating hyperlipoproteinemia and its preparing method | |
CN1317010C (en) | Huoliguan dripping pill for tonifying heart and kidney and its preparing method | |
CN1686340A (en) | Gastrodia brain arousing drip pill for nourishing liver and kidney and its preparation method | |
CN1316962C (en) | Cough panting quieting drip pill and its preparation method | |
CN1682804A (en) | Oral administration dripping pill for nourishing heart to calm mind and its preparing method | |
CN1686339A (en) | Compound cynomorium drip pill and its preparation method | |
CN1682803A (en) | Dripping pill made from haw, chrysanthemum and Chinese wolfberry fruit and its preparing method | |
CN1686515A (en) | Cordyceps drip pill used for nourishing lung and kidney and its preparation method | |
CN1292740C (en) | Ginseng and Chinese angelica root dripping pill and its preparing method | |
CN1292739C (en) | Shenerwuwei dripping pill for benefiting qi and nourishing yin and its preparing method | |
CN1686518A (en) | Ganoderma astragalus drip pill for treating heart spleen vacuity and its preparation method | |
CN1686338A (en) | Shuxin anshen drip pill used for fortifying brain quieting heart and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |